JP2005511608A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511608A5
JP2005511608A5 JP2003542177A JP2003542177A JP2005511608A5 JP 2005511608 A5 JP2005511608 A5 JP 2005511608A5 JP 2003542177 A JP2003542177 A JP 2003542177A JP 2003542177 A JP2003542177 A JP 2003542177A JP 2005511608 A5 JP2005511608 A5 JP 2005511608A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
hydrogen
aryl
alkylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003542177A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005511608A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/012164 external-priority patent/WO2003040131A1/en
Publication of JP2005511608A publication Critical patent/JP2005511608A/ja
Publication of JP2005511608A5 publication Critical patent/JP2005511608A5/ja
Pending legal-status Critical Current

Links

JP2003542177A 2001-11-07 2002-10-31 アミノピリミジン類及び−ピリジン類 Pending JP2005511608A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33831201P 2001-11-07 2001-11-07
PCT/EP2002/012164 WO2003040131A1 (en) 2001-11-07 2002-10-31 Aminopyrimidines and pyridines

Publications (2)

Publication Number Publication Date
JP2005511608A JP2005511608A (ja) 2005-04-28
JP2005511608A5 true JP2005511608A5 (https=) 2006-01-05

Family

ID=23324288

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003542177A Pending JP2005511608A (ja) 2001-11-07 2002-10-31 アミノピリミジン類及び−ピリジン類

Country Status (12)

Country Link
US (2) US6846828B2 (https=)
EP (1) EP1444223A1 (https=)
JP (1) JP2005511608A (https=)
KR (1) KR20050042062A (https=)
CN (1) CN1582284A (https=)
AR (1) AR039554A1 (https=)
BR (1) BR0213899A (https=)
CA (1) CA2465711A1 (https=)
MX (1) MXPA04004166A (https=)
PL (1) PL370480A1 (https=)
RU (1) RU2308455C2 (https=)
WO (1) WO2003040131A1 (https=)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021726D0 (en) * 2000-09-05 2000-10-18 Astrazeneca Ab Chemical compounds
GB0205688D0 (en) * 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
US7442697B2 (en) * 2002-03-09 2008-10-28 Astrazeneca Ab 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
GB0205693D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
GB0205690D0 (en) * 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
WO2004041285A1 (en) 2002-10-31 2004-05-21 Amgen Inc. Antiinflammation agents
CN100441569C (zh) * 2003-02-24 2008-12-10 横滨橡胶株式会社 化合物和使用了该化合物的组合物
GB0311276D0 (en) * 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
GB0311274D0 (en) * 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
CA2541667A1 (en) * 2003-10-14 2005-04-21 Pharmacia Corporation Substituted pyrazinone compounds for the treatment of inflammation
TW200533357A (en) * 2004-01-08 2005-10-16 Millennium Pharm Inc 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
TW200528101A (en) * 2004-02-03 2005-09-01 Astrazeneca Ab Chemical compounds
EP2311827A1 (en) * 2004-08-28 2011-04-20 AstraZeneca AB Thiopyrimidine derivative, useful as an intermediate for chemokine receptor modulators.
MX2007007272A (es) * 2004-12-17 2007-07-11 Astrazeneca Ab 4-(4-imidazol-4-il)pirimidin-2-ilamino)benzamidas como inhibidores de cdk.
GB0514017D0 (en) * 2005-07-07 2005-08-17 Ionix Pharmaceuticals Ltd Chemical compounds
JP4278172B2 (ja) * 2005-07-30 2009-06-10 アストラゼネカ アクチボラグ 増殖性疾患の治療において使用するためのイミダゾリル−ピリミジン化合物
AR056556A1 (es) * 2005-09-30 2007-10-10 Astrazeneca Ab Imidazo(1,2-a)piridina con actividad antiproliferacion celular
AR058277A1 (es) * 2005-12-09 2008-01-30 Solvay Pharm Gmbh N- sulfamoil - piperidin - amidas, composiciones farmaceuticas que las comprenden y procedimiento para su preparacion
TW200811169A (en) * 2006-05-26 2008-03-01 Astrazeneca Ab Chemical compounds
WO2008127302A2 (en) * 2006-10-27 2008-10-23 Genyous BioMed International, Inc. Compositions for treatment and inhibition of pain
JP2013512674A (ja) * 2009-12-02 2013-04-18 アクセルロン ファーマ, インコーポレイテッド Fc融合タンパク質の血清半減期を増加させるための組成物および方法
US8754114B2 (en) 2010-12-22 2014-06-17 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
EP2718328A4 (en) 2011-06-08 2014-12-24 Acceleron Pharma Inc COMPOSITIONS AND METHODS FOR INCREASING THE HALF TIME OF SERUM
RS58514B1 (sr) 2012-06-13 2019-04-30 Incyte Holdings Corp Supstituisana triciklična jedinjenja kao inhibitori fgfr
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
PH12015502383B1 (en) 2013-04-19 2023-02-03 Incyte Holdings Corp Bicyclic heterocycles as fgfr inhibitors
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
TWI712601B (zh) 2015-02-20 2020-12-11 美商英塞特公司 作為fgfr抑制劑之雙環雜環
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
WO2019099307A1 (en) * 2017-11-17 2019-05-23 Hepagene Therapeutics, Inc. Urea derivatives as inhibitors of ask1
HRP20241288T1 (hr) 2018-05-04 2024-12-06 Incyte Corporation Čvrsti oblici fgfr inhibitora i postupci za njihovu proizvodnju
AU2019262579B2 (en) 2018-05-04 2024-09-12 Incyte Corporation Salts of an FGFR inhibitor
KR102441327B1 (ko) * 2018-05-18 2022-09-07 주식회사유한양행 다이아미노피리미딘 유도체 또는 이의 산부가염의 신규의 제조방법
CN109336800B (zh) * 2018-09-17 2022-11-29 江西中医药大学 一种dhnb缩苯基氨基硫脲化合物及其制备方法和用途
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
CA3157361A1 (en) 2019-10-14 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
JP7832891B2 (ja) 2019-12-04 2026-03-18 インサイト・コーポレイション Fgfr阻害剤の誘導体
CA3163875A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2022221170A1 (en) 2021-04-12 2022-10-20 Incyte Corporation Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
CA3220155A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
US11939331B2 (en) 2021-06-09 2024-03-26 Incyte Corporation Tricyclic heterocycles as FGFR inhibitors
CN115919864B (zh) * 2022-12-02 2024-09-03 中南大学湘雅三医院 唑嘧啶胺类化合物在用于制备治疗ibd药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2095240A (en) * 1981-03-05 1982-09-29 Fujisawa Pharmaceutical Co Dihydropyrimidine derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
DE59106752D1 (de) 1990-05-16 1995-11-30 Sulzer Chemtech Ag Verfahren zur gerichteten fraktionierten Kristallisation.
EP0457727A1 (de) * 1990-05-17 1991-11-21 Ciba-Geigy Ag Schädlingsbekämpfungsmittel
IL106786A (en) * 1992-09-10 1997-02-18 Basf Ag Substituted pyridine derivatives and fungicidal compositions containing them
WO1995010506A1 (en) * 1993-10-12 1995-04-20 The Du Pont Merck Pharmaceutical Company 1n-alkyl-n-arylpyrimidinamines and derivatives thereof
ES2250363T3 (es) * 2000-02-02 2006-04-16 Dorian Bevec Guanilhidrazonas aromaticas farmaceuticamente activas.
ES2305125T3 (es) * 2000-10-26 2008-11-01 Amgen Inc. Agentes anti-inflamatorios.

Similar Documents

Publication Publication Date Title
JP2005511608A5 (https=)
RU2004117545A (ru) Аминопиримидины и пиридины
CN100355751C (zh) 2-取代的4-杂芳基-嘧啶、其组合物及其用途
JP6193922B2 (ja) ハロアルキルヘテロアリールベンズアミド化合物
US6924302B2 (en) Substituted triazole diamine derivatives as kinase inhibitors
JP2568315B2 (ja) 縮合環アリール置換イミダゾール
JP2550442B2 (ja) 置換イミダゾール
JP2001526230A (ja) ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用
DE08851028T1 (de) Verwendung von crth2-antagonisten-verbindungen
RU2007146798A (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
EA016887B1 (ru) ЗАМЕЩЁННЫЕ ФЕНОКСИАМИНОТИАЗОЛОНЫ В КАЧЕСТВЕ МОДУЛЯТОРОВ РОДСТВЕННОГО ЭСТРОГЕНОВОМУ РЕЦЕПТОРУ РЕЦЕПТОРА-α
JP2005526028A5 (https=)
JP2002505690A (ja) 新規なアリールオキシピリミジン置換イミダゾール化合物
EP2107054A1 (en) Antiproliferative compounds and therapeutic uses thereof
JP2002528506A (ja) ピリジン−4−イルまたはピリミジン−4−イル置換ピラジン
JP2001518507A (ja) 新規シクロアルケニル置換化合物
AU2017444054B2 (en) Class of pyrimidine derivative kinase inhibitors
JP2022511477A5 (https=)
AU2005221131A1 (en) Ion channel modulators
CA2617991A1 (en) N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
CA2557650A1 (en) Ion channel modulators
AU2005231123A1 (en) Ion channel modulators
JPWO2020179859A5 (https=)
JP2012528843A5 (https=)
CA2558217A1 (en) Ion channel modulators